
Trent R. Clarke
Examiner (ID: 9262, Phone: (571)272-2904 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651 |
| Total Applications | 507 |
| Issued Applications | 172 |
| Pending Applications | 83 |
| Abandoned Applications | 270 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20527503
[patent_doc_number] => 12545930
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-02-10
[patent_title] => Cochlear inner hair cell promoters and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/734246
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10443
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734246
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734246 | Cochlear inner hair cell promoters and uses thereof | May 1, 2022 | Issued |
Array
(
[id] => 19265712
[patent_doc_number] => 20240209411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => METHOD FOR STERILITY TESTING
[patent_app_type] => utility
[patent_app_number] => 18/288304
[patent_app_country] => US
[patent_app_date] => 2022-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288304
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288304 | METHOD FOR STERILITY TESTING | Apr 25, 2022 | Pending |
Array
(
[id] => 17777799
[patent_doc_number] => 20220244148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Composition and Method for Disrupting Tissue Material
[patent_app_type] => utility
[patent_app_number] => 17/727425
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17727425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/727425 | Composition and Method for Disrupting Tissue Material | Apr 21, 2022 | Abandoned |
Array
(
[id] => 19250197
[patent_doc_number] => 20240201185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => MARKERS OF AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/556496
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556496
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/556496 | MARKERS OF AUTOIMMUNE DISEASES | Apr 20, 2022 | Pending |
Array
(
[id] => 17944368
[patent_doc_number] => 20220331385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => ANTI-CANCER ONCOLYTIC VIRUS COMBINATION THERAPIES AND ELITE RESPONDER SELECTION PLATFORMS
[patent_app_type] => utility
[patent_app_number] => 17/660051
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17660051
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/660051 | ANTI-CANCER ONCOLYTIC VIRUS COMBINATION THERAPIES AND ELITE RESPONDER SELECTION PLATFORMS | Apr 20, 2022 | Abandoned |
Array
(
[id] => 17789899
[patent_doc_number] => 20220248990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => GLUCOSE DETECTING COMPLEX AND CONTACT LENS-TYPE SENSOR COMPRISING SAME FOR DETECTING GLUCOSE IN TEARS
[patent_app_type] => utility
[patent_app_number] => 17/725353
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17725353
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/725353 | GLUCOSE DETECTING COMPLEX AND CONTACT LENS-TYPE SENSOR COMPRISING SAME FOR DETECTING GLUCOSE IN TEARS | Apr 19, 2022 | Pending |
Array
(
[id] => 17749982
[patent_doc_number] => 20220228187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SERUM-FREE CELL CULTURE MEDIUM
[patent_app_type] => utility
[patent_app_number] => 17/712697
[patent_app_country] => US
[patent_app_date] => 2022-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712697
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/712697 | Serum-free cell culture medium | Apr 3, 2022 | Issued |
Array
(
[id] => 17702848
[patent_doc_number] => 20220202854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => HUMAN FACILITATING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/693500
[patent_app_country] => US
[patent_app_date] => 2022-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17693500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/693500 | HUMAN FACILITATING CELLS | Mar 13, 2022 | Abandoned |
Array
(
[id] => 18503611
[patent_doc_number] => 11701401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Herbal composition in powder, pill or liquid form for speeding up fracture healing and bone regeneration and herbal formulation in powder, pill or liquid form containing the same
[patent_app_type] => utility
[patent_app_number] => 17/692579
[patent_app_country] => US
[patent_app_date] => 2022-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 5253
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692579
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/692579 | Herbal composition in powder, pill or liquid form for speeding up fracture healing and bone regeneration and herbal formulation in powder, pill or liquid form containing the same | Mar 10, 2022 | Issued |
Array
(
[id] => 17670973
[patent_doc_number] => 20220184140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => USE OF ADHERENT STROMAL CELLS FOR ENHANCING HEMATOPOIESIS IN A SUBJECT IN NEED THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/687799
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22310
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687799
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687799 | USE OF ADHERENT STROMAL CELLS FOR ENHANCING HEMATOPOIESIS IN A SUBJECT IN NEED THEREOF | Mar 6, 2022 | Abandoned |
Array
(
[id] => 20375602
[patent_doc_number] => 12483047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Compositions and methods for treating and preventing macular degeneration
[patent_app_type] => utility
[patent_app_number] => 17/681468
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 24
[patent_no_of_words] => 17670
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681468
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681468 | Compositions and methods for treating and preventing macular degeneration | Feb 24, 2022 | Issued |
Array
(
[id] => 19258274
[patent_doc_number] => 12018320
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-25
[patent_title] => Selective oxidation of 5-methylcytosine by TET-family proteins
[patent_app_type] => utility
[patent_app_number] => 17/675502
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 89
[patent_no_of_words] => 58643
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/675502 | Selective oxidation of 5-methylcytosine by TET-family proteins | Feb 17, 2022 | Issued |
Array
(
[id] => 19556869
[patent_doc_number] => 20240368661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => COMPOSITIONS AND METHODS FOR PRODUCING REBAUDIOSIDE D
[patent_app_type] => utility
[patent_app_number] => 18/546881
[patent_app_country] => US
[patent_app_date] => 2022-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546881
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546881 | COMPOSITIONS AND METHODS FOR PRODUCING REBAUDIOSIDE D | Feb 16, 2022 | Pending |
Array
(
[id] => 19067642
[patent_doc_number] => 20240102068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => C-GLYCOSYLTRANSFERASE VARIANTS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/263127
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263127
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263127 | C-GLYCOSYLTRANSFERASE VARIANTS AND USE THEREOF | Jan 26, 2022 | Pending |
Array
(
[id] => 20207483
[patent_doc_number] => 20250277203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-04
[patent_title] => EXPRESSION VECTORS COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/265659
[patent_app_country] => US
[patent_app_date] => 2021-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265659
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/265659 | EXPRESSION VECTORS COMPOSITION | Dec 6, 2021 | Pending |
Array
(
[id] => 18903043
[patent_doc_number] => 20240018528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => A TUNABLE PHOSPHORYLATION-BASED FEEDBACK CONTROLLER OF MAMMALIAN GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/039583
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -92
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039583
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/039583 | A TUNABLE PHOSPHORYLATION-BASED FEEDBACK CONTROLLER OF MAMMALIAN GENE EXPRESSION | Dec 1, 2021 | Pending |
Array
(
[id] => 20173181
[patent_doc_number] => 12391915
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Maintenance of differentiated cells with laminins
[patent_app_type] => utility
[patent_app_number] => 17/511079
[patent_app_country] => US
[patent_app_date] => 2021-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 3838
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511079
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/511079 | Maintenance of differentiated cells with laminins | Oct 25, 2021 | Issued |
Array
(
[id] => 17385920
[patent_doc_number] => 20220033772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => FACTOR RICH PRODUCTS FROM UMBILICAL CORD MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/501775
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501775
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501775 | Lyophilized compositions containing umbilical cord lining stem cells conditioned medium | Oct 13, 2021 | Issued |
Array
(
[id] => 18787263
[patent_doc_number] => 20230375528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => SCREENING METHOD FOR THE IDENTIFICATION OF NOVEL THERAPEUTIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/248022
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17830
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248022
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248022 | SCREENING METHOD FOR THE IDENTIFICATION OF NOVEL THERAPEUTIC COMPOUNDS | Oct 5, 2021 | Pending |
Array
(
[id] => 17382999
[patent_doc_number] => 20220030851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => MODULATING ISCHEMIC INJURY
[patent_app_type] => utility
[patent_app_number] => 17/494690
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494690
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/494690 | MODULATING ISCHEMIC INJURY | Oct 4, 2021 | Pending |